Expert Opinion on Therapeutic Targets

1.0(top 50%)

impact factor

226(top 50%)

papers

817(top 50%)

citations

15(top 50%)

h-index

1.1(top 50%)

impact factor

230

all documents

827

doc citations

25(top 50%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Matrix metalloproteinases as emerging targets in anticancer therapy: status and prospects	Expert Opinion on Therapeutic Targets	2000	67
2	Heat shock proteins: new keys to the development of cytoprotective therapies	Expert Opinion on Therapeutic Targets	2001	63
3	GABA signalling: therapeutic targets for epilepsy, Parkinson’s disease and Huntington’s disease	Expert Opinion on Therapeutic Targets	2001	46
4	Adenosine receptors in neurological disorders	Expert Opinion on Therapeutic Targets	2000	36
5	Peptide deformylase: a target for novel antibiotics?	Expert Opinion on Therapeutic Targets	2001	32
6	A return to rational drug discovery: computer-based models of cells, organs and systems in drug target identification	Expert Opinion on Therapeutic Targets	2000	31
7	Sarcoplasmic reticulum and cardiac oxidative stress: an emerging target for heart disease	Expert Opinion on Therapeutic Targets	2001	31
8	The identification of quality antibacterial drug discovery targets: a case study with aminoacyl-tRNA synthetases	Expert Opinion on Therapeutic Targets	2000	23
9	Peptide deformylase as an emerging target for antiparasitic agents	Expert Opinion on Therapeutic Targets	2001	23
10	Chromatin organisation and human disease	Expert Opinion on Therapeutic Targets	2000	22
11	Endocannabinoids Part I: Molecular basis of endocannabinoid formation, action and inactivation and development of selective inhibitors	Expert Opinion on Therapeutic Targets	2001	21
12	New potential targets for antifungal development	Expert Opinion on Therapeutic Targets	2000	20
13	Soluble guanylate cyclase	Expert Opinion on Therapeutic Targets	2000	16
14	Emerging therapeutic targets in oncology: urokinase-type plasminogen activator system	Expert Opinion on Therapeutic Targets	1999	15
15	Thromboregulatory potential of endothelial CD39/nucleoside triphosphate diphosphohydrolase: modulation of purinergic signalling in platelets	Expert Opinion on Therapeutic Targets	2000	15
16	Nucleoside transporter proteins: emerging targets for drug discovery	Expert Opinion on Therapeutic Targets	2000	15
17	Excitatory amino acid transporters as emerging targets for central nervous system therapeutics	Expert Opinion on Therapeutic Targets	1999	14
18	The adipocyte cGMP-inhibited cyclic nucleotide phosphodiesterase (PDE3B) as a target for lipolytic and thermogenic agents for the treatment of obesity	Expert Opinion on Therapeutic Targets	1999	14
19	Integrins as novel drug discovery targets: potential therapeutic and diagnostic implications	Expert Opinion on Therapeutic Targets	2000	14
20	Emerging therapeutic targets in asthma: the rationale for mast cell tryptase inhibition	Expert Opinion on Therapeutic Targets	1999	13
21	Structural basis for the action of drugs that affect microtubule dynamics	Expert Opinion on Therapeutic Targets	2000	13
22	The HIV-1 Nef protein as a target for antiretroviral therapy	Expert Opinion on Therapeutic Targets	2001	13
23	Sec, drugs and rock’n’roll: antibiotic targeting of bacterial protein translocation	Expert Opinion on Therapeutic Targets	2001	12
24	Yeast as a model system for anticancer drug discovery	Expert Opinion on Therapeutic Targets	2001	12
25	Emerging therapeutic targets in caspase-dependent disease	Expert Opinion on Therapeutic Targets	1999	11
26	Subarachnoid haemorrhage-induced cerebral vasospasm: a subcellular perspective on the control of tension	Expert Opinion on Therapeutic Targets	1999	10
27	The retinoblastoma gene family: its role in cancer onset and progression	Expert Opinion on Therapeutic Targets	2000	9
28	Expression of heme oxygenase-1 by endothelial cells: a protective response to injury in transplantation	Expert Opinion on Therapeutic Targets	2000	9
29	Combating antimicrobial resistance in hospitals	Expert Opinion on Therapeutic Targets	1999	7
30	Biosystems modelling for in silico target validation: challenges to implementation	Expert Opinion on Therapeutic Targets	2000	7
31	Kinin B1receptors as novel anti-inflammatory targets	Expert Opinion on Therapeutic Targets	2000	7
32	Ubiquitin- and proteasome-dependent pathway of protein degradation as an emerging therapeutic target	Expert Opinion on Therapeutic Targets	2000	7
33	Emerging therapeutic targets in the eradication of Helicobacter pylori	Expert Opinion on Therapeutic Targets	1998	6
34	Potential therapeutic targets for Alzheimer’s disease	Expert Opinion on Therapeutic Targets	1998	6
35	Cytokines in inflammatory diseases: role and therapeutic targets in acute respiratory distress syndrome	Expert Opinion on Therapeutic Targets	1998	6
36	New ABC transporters in multi-drug resistance	Expert Opinion on Therapeutic Targets	2000	6
37	A new frontier in pharmacology: the endoplasmic reticulum as a regulated export pathway in health and disease	Expert Opinion on Therapeutic Targets	2001	6
38	The emerging utility of animal models of chronic neurodegenerative diseases	Expert Opinion on Therapeutic Targets	2001	6
39	ETS transcription factors and targets in tumour invasion, angiogenesis and bone metastasis	Expert Opinion on Therapeutic Targets	2001	6
40	Centrally-Acting Antagonist of Muscarinic M4 Receptors	Expert Opinion on Therapeutic Targets	1997	5
41	Emerging therapeutic targets in focal stroke and brain trauma: cytokines and the brain inflammatory response to injury	Expert Opinion on Therapeutic Targets	1998	5
42	Molecular interactions involving urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor, plasminogen activator inhibitor-1 (PAI-1), as new targets for tumour therapy	Expert Opinion on Therapeutic Targets	1999	5
43	Caveolin-1: a complex and provocative therapeutic target in prostate cancer and potentially other malignancies	Expert Opinion on Therapeutic Targets	1999	5
44	Integrins as therapeutic targets	Expert Opinion on Therapeutic Targets	2000	5
45	EGFRvIII: an oncogene deletion mutant cell surface receptor target expressed by multiple tumour types	Expert Opinion on Therapeutic Targets	2000	5
46	The role of the mitochondrion in smooth muscle cell fate choices of proliferation versus apoptosis during vascular and cardiovascular diseases	Expert Opinion on Therapeutic Targets	1999	4
47	Emerging therapeutics for diabetic retinopathy: potential therapies for the new millennium	Expert Opinion on Therapeutic Targets	1999	4
48	Emerging therapeutic cell wall targets in fungal infections	Expert Opinion on Therapeutic Targets	1999	4
49	Emerging therapeutic targets in allergy: IL-4Rα and Stat6	Expert Opinion on Therapeutic Targets	1999	4
50	Nuclear receptors in metabolic diseases	Expert Opinion on Therapeutic Targets	2000	4

Scientometrics

Overviews

Citing Bodies

Expert Opinion on Therapeutic Targets

Top Articles